About

Kavira is an independent resource on ibogaine, its potential uses, risks, evidence, regulation, and cultural context. We focus on clear, evidence-first information and an honest presentation of uncertainty and safety considerations.

This page describes who runs the resource, how we approach sourcing and review, and our editorial principles. For topical coverage and reporting, our homepage presents curated material and investigations.

For readers exploring treatment and services, our services overview situates what kinds of resources exist; for example, we link to clinical and programmatic descriptions on third-party pages when relevant such as the detailed treatment resource at ibogaine for opioid addiction.

Why Kavira exists

Our mission is to support clear understanding of urgent treatment needs alongside non-negotiable safety considerations.

We produce explanatory material, syntheses of existing research, regulatory context, and plain-language guidance about how the evidence is gathered and where it is limited. Our work is independent: we are not a clinic, medical provider, or licensed treatment center, and we do not offer medical or legal advice.

Who this is for

Kavira serves people affected by substance use, family members, researchers, policymakers, and anyone seeking grounded information.

How to navigate our site

Content is organized into topical areas (overview, safety, regulation, and resources). If you arrived here from another section, you can always return to our main gateway to topical content by visiting the site index at the Kavira homepage, or consult our summaries under Services for how we categorize resources and links.

Our editorial approach

We assemble material from registries, peer-reviewed journals, regulatory documents, and primary legal sources; we cross-check claims against official pages and recognized repositories. For instance, when describing clinical evidence we reference established literature registries and institutional resources such as the National Library of Medicine (PubMed) and public health guidance from government health agencies.

Transparency
Evidence-first
Safety focus
Cultural respect

To back our claims about evidence standards we cite recognized authorities: for methods on systematic reviews we use guidance like that summarized on the Systematic review overview, and for clinical trial reporting we consult registries such as the ClinicalTrials.gov database.

Sourcing, review, and updates

Our editorial workflow begins with primary sources: published studies, registries, regulatory filings, and institutional guidance. Content is fact-checked against original publications rather than second-hand summaries.

We also link to reputable third-party resources when they provide operational information; for example, discussions about treatment programs and practice options sometimes point to domain-specific pages such as ibogaine for opioid addiction where service descriptions are hosted externally.

We record update dates on substantive pages and revisit major topics when significant new evidence or regulatory changes occur. For legal and policy summaries we consult official government pages and institutional policy statements.

Example authoritative sites we consult include the U.S. National Institutes of Health and university-hosted literature repositories to confirm study details and safety signals; when we quote or summarize such material we link directly to the original source in context.

Editorial principles

  • Independence: We do not accept compensation that would influence editorial judgments.
  • Safety first: We foreground risk, monitoring needs, and situations where care should be sought.
  • Evidence before claims: We privilege peer-reviewed and registry information over anecdote.
  • Plain language: We aim for clarity so readers from varied backgrounds can understand the limits of the evidence.
  • Cultural respect: We acknowledge traditional contexts and avoid appropriation when describing cultural practices.

Independent by design

Kavira is an independent information resource, not a clinic, medical provider, or licensed treatment center. Our content is not medical or legal advice. If you need care or legal guidance, consult a qualified professional. For general background on substance-use policy and public health frameworks, authoritative resources include the U.S. Centers for Disease Control and Prevention at cdc.gov.

Connect with our site structure

Explore topic areas, safety resources, and our summarized services to find the information you need; our Services page explains how we group content and external resource links so you can quickly find relevant material.

See Services Contact Kavira

Frequently asked — editorial

How do you choose sources?

We prioritize primary literature, registered trials, and official regulatory documents; we avoid relying solely on anecdotal reports. Where appropriate we link to public registries such as ClinicalTrials.gov to show trial registration and basic protocol details.

Do you provide medical advice?

No. Kavira is an information resource and does not provide medical, legal, or treatment advice. For medical decisions consult licensed professionals or local public-health services such as those listed by public health departments.

Where can I find practical program listings?

We link to third-party program descriptions and directories when available; one such external resource is ibogaine for opioid addiction, which hosts program-level information that we reference in context rather than endorse.